Safety of Propranolol Therapy for Severe Infantile Hemangioma

JAMA. 2016 Jan 26;315(4):413-5. doi: 10.1001/jama.2015.13969.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Causality
  • Child
  • Child, Preschool
  • Compassionate Use Trials*
  • Female
  • France
  • Hemangioma / drug therapy*
  • Humans
  • Infant
  • Male
  • Off-Label Use*
  • Propranolol / administration & dosage
  • Propranolol / adverse effects*

Substances

  • Antineoplastic Agents
  • Propranolol